BOULDER, Colo., Feb. 5, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. 



    Event:                                          Leerink Swann Healthcare Conference

    Presenter:                                      Ron Squarer, Chief Executive Officer

    Date:                                           Wednesday, February 11, 2015

    Time:                                           10:15 a.m. Eastern Time

    Location:                                       The Waldorf Astoria, New York, NY

    Webcast:

    http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-
     EventDetails&EventId=5184603

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com



    CONTACT:                        Tricia Haugeto

                                    Array BioPharma Inc.

                                    303-386-1193

                                    thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-leerink-swann-global-healthcare-conference-300031621.html

SOURCE Array BioPharma Inc.